title: Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease.
abstract: Hyposmia, psychiatric disorders, and cognitive problems are common nonmotor manifestations in Parkinson's disease, but how they are related remains unclear. We investigated the relationship between olfactory dysfunction and neuropsychiatric manifestations and performed a cross-sectional study of 248 patients at two movement disorders clinics at academic medical centers. Psychiatric measures were the Geriatric Depression Scale-15, Inventory of Depressive Symptomatology, State Anxiety Inventory, Apathy Scale, and Parkinson's Psychosis Rating Scale. Cognitive measures were the Mini-Mental State Examination, Hopkins Verbal Learning Test-Revised, Digit Span, Tower of London-Drexel, and the Stroop Color Word Test. Olfaction was tested with the University of Pennsylvania Smell Identification Test. There was no significant association between olfaction and mood measures, but psychotic symptoms were more common in patients with olfaction scores below the median (30% vs. 12%; P < 0.001). Worse olfaction was associated with poorer memory (Hopkins Verbal Learning Test-Revised delayed recall items: mean [standard deviation], 6.2 [3.2] vs. 8.4 [2.8]; P < 0.001) and executive performance (Tower of London total moves, 52 [38] vs. 34 [21]; P < 0.001). Odor-identification score was a significant predictor of abnormal performance on these cognitive tests after adjustment for age, sex, and disease characteristics in logistic regression models. The relationship between hyposmia, psychosis, and specific cognitive impairments may reflect the anatomic distribution of Lewy pathology and suggests that olfactory dysfunction could be a biomarker of additional extranigral disease. Future prospective studies are warranted to assess whether hyposmia, a very early feature of Parkinson's disease, might be used to predict the appearance of other common nonmotor symptoms.
authors: Parkinson's Disease Research, Education and Clinical Center, Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA.
authors: James F
authors: JF
authors: Morley
authors: Daniel
authors: D
authors: Weintraub
authors: Eugenia
authors: E
authors: Mamikonyan
authors: Paul J
authors: PJ
authors: Moberg
authors: Andrew D
authors: AD
authors: Siderowf
authors: John E
authors: JE
authors: Duda
references: Mov Disord. 2007 Apr 30;22(6):839-42
references: 17357143
references: Brain. 2010 Jun;133(Pt 6):1747-54
references: 20413575
references: Mov Disord. 2010;25 Suppl 1:S123-30
references: 20187234
references: Neurosignals. 2008;16(1):35-40
references: 18097158
references: Parkinsonism Relat Disord. 2010 Feb;16(2):124-6
references: 19783195
references: Neurology. 2000 May 23;54(10):1916-21
references: 10822429
references: J Chronic Dis. 1975 Oct;28(9):493-7
references: 1176578
references: Clin Neuropharmacol. 1998 Sep-Oct;21(5):280-4
references: 9789707
references: Neurology. 2010 Mar 16;74(11):924-31
references: 20231670
references: J Neurol. 2010 Jun;257(6):969-76
references: 20119648
references: Percept Psychophys. 1994 Dec;56(6):701-7
references: 7816540
references: J Neural Transm (Vienna). 2002 May;109(5-6):805-11
references: 12111470
references: Ann Neurol. 2008 Feb;63(2):167-73
references: 18067173
references: Neurology. 2010 Jan 19;74(3):245-51
references: 20083801
references: Neurology. 2010 Sep 21;75(12):1062-9
references: 20855849
references: Neurology. 2008 Dec 2;71(23):1877-82
references: 19047559
references: Mov Disord. 2010 Oct 15;25(13):2099-104
references: 20669288
references: Physiol Behav. 1984 Mar;32(3):489-502
references: 6463130
references: Psychiatry Res. 1986 May;18(1):65-87
references: 3737788
references: Chem Senses. 2008 Jan;33(1):17-21
references: 17761724
references: J Psychiatr Res. 1975 Nov;12(3):189-98
references: 1202204
references: J Neuropsychiatry Clin Neurosci. 1992 Spring;4(2):134-9
references: 1627973
references: Arch Neurol. 1999 Jan;56(1):33-9
references: 9923759
references: Neurology. 1967 May;17(5):427-42
references: 6067254
references: Parkinsonism Relat Disord. 2009 Mar;15(3):226-31
references: 18595765
references: Ann Neurol. 2004 Aug;56(2):173-81
references: 15293269
references: Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
references: 12498954
references: Mov Disord. 2008 Jun 15;23(8):1076-84
references: 18442121
references: J Am Geriatr Soc. 2009 Feb;57(2):304-8
references: 19170786
references: J Neurol. 2008 Mar;255(3):367-70
references: 18343969
references: Neurosci Lett. 2010 Dec 17;486(3):166-70
references: 20858529
references: Mov Disord. 2010;25 Suppl 1:S89-93
references: 20187248
references: Neurology. 1988 Aug;38(8):1237-44
references: 3399075
references: Mov Disord. 2006 Dec;21(12):2042-51
references: 17078043
references: Mov Disord. 2009 Nov 15;24(15):2175-86
references: 19768724
references: Biomark Med. 2010 Oct;4(5):661-70
references: 20945979
references: Mov Disord. 2001 Jan;16(1):41-6
references: 11215591
references: Mov Disord. 2010 Jul 15;25(9):1143-9
references: 20131383
references: Neurology. 2009 Mar 31;72(13):1121-6
references: 19020293
references: Mov Disord. 2009;24 Suppl 2:S665-70
references: 19877244
references: Mov Disord. 2008 Oct 30;23(14):1984-90
references: 18759360
references: Mov Disord. 2009 Aug 15;24(11):1641-9
references: 19514014
references: Parkinsonism Relat Disord. 2007;13 Suppl 3:S225-8
references: 18267240
references: Neurology. 1997 Nov;49(5):1424-31
references: 9371933